Save your place

Sign in to WhoBought

Please try again later.

Ray Dalio's Edwards Lifesciences Corporation (EW) position

Yes: as of Q1 2026, Ray Dalio holds 172K shares of EW worth $14M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$14M
Shares held
172K
% of portfolio
0.1%
Est. average buy price (i)
$78.84
est. since Q3 2024
Quarter-end price
$80.08

Estimated trade prices

Average price in quarters with purchases
$91.66
Average prices in quarters with sales
  • Q4 2025: $82.07 (104K shares sold)
  • Q3 2025: $78.13 (265K shares sold)
  • Q1 2025: $71.57 (46K shares sold)
  • Q4 2024: $69.99 (57K shares sold)
  • Q1 2024: $84.00 (418K shares sold)
  • Q4 2023: $69.58 (152K shares sold)
  • Q2 2023: $86.92 (161K shares sold)
  • Q4 2022: $77.07 (224K shares sold)
  • Q2 2022: $103.52 (140K shares sold)
  • Q3 2021: $114.14 (8K shares sold)

EW price vs Dalio's position

Dates
$50$100$15020222023202420252026Sold 8K shares (1.1%) · Q3 2021. Average closing price $114.14 · Price range $102.91–$122.758KsharessoldAdded 117K shares (17.0%) · Q4 2021. Average closing price $116.64 · Price range $106.37–$130.68117KsharespurchasedAdded 328K shares (40.7%) · Q1 2022. Average closing price $112.18 · Price range $101.96–$128.34328KsharespurchasedSold 140K shares (12.3%) · Q2 2022. Average closing price $103.52 · Price range $86.50–$128.27140KsharessoldAdded 135K shares (13.6%) · Q3 2022. Average closing price $96.22 · Price range $82.37–$107.29135KsharespurchasedSold 224K shares (19.8%) · Q4 2022. Average closing price $77.07 · Price range $68.54–$87.44224KsharessoldAdded 37K shares (4.0%) · Q1 2023. Average closing price $78.60 · Price range $74.27–$84.5137KsharespurchasedSold 161K shares (17.1%) · Q2 2023. Average closing price $86.92 · Price range $81.41–$94.33161KsharessoldAdded 273K shares (34.9%) · Q3 2023. Average closing price $80.36 · Price range $69.28–$93.38273KsharespurchasedSold 152K shares (14.4%) · Q4 2023. Average closing price $69.58 · Price range $61.71–$77.76152KsharessoldSold 418K shares (46.2%) · Q1 2024. Average closing price $84.00 · Price range $72.54–$95.56418KsharessoldAdded 34K shares (7.0%) · Q2 2024. Average closing price $88.55 · Price range $84.30–$94.3134KsharespurchasedSold 57K shares (34.6%) · Q4 2024. Average closing price $69.99 · Price range $64.54–$75.9257KsharessoldSold 46K shares (42.3%) · Q1 2025. Average closing price $71.57 · Price range $67.95–$76.1946KsharessoldAdded 382K shares (611.6%) · Q2 2025. Average closing price $74.58 · Price range $67.07–$78.22382KsharespurchasedSold 265K shares (59.5%) · Q3 2025. Average closing price $78.13 · Price range $73.75–$81.83265KsharessoldSold 104K shares (57.4%) · Q4 2025. Average closing price $82.07 · Price range $72.65–$86.94104KsharessoldAdded 95K shares (124.0%) · Q1 2026. Average closing price $82.49 · Price range $76.44–$87.1895Ksharespurchased← Earlier —1 purchase
Average closing price · filing quarter
$82.49
Price range · filing quarter
$76.44 – $87.18

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +95K +$7.9M +124.0% 172K May 15, 2026
Q4 2025 Reduced −104K −$8.5M −57.4% 77K Feb 13, 2026
Q3 2025 Reduced −265K −$21M −59.5% 180K Nov 13, 2025
Q2 2025 Added +382K +$29M +611.6% 445K Aug 13, 2025
Q1 2025 Reduced −46K −$3.3M −42.3% 63K May 14, 2025
Q4 2024 Reduced −57K −$4.0M −34.6% 108K Feb 13, 2025
Q3 2024 First covered 165K Nov 13, 2024
Q2 2024 Added +34K +$3.0M +7.0% 520K Aug 14, 2024
Q1 2024 Reduced −418K −$35M −46.2% 486K May 14, 2024
Q4 2023 Reduced −152K −$11M −14.4% 903K Feb 14, 2024
Q3 2023 Added +273K +$22M +34.9% 1.1M Nov 13, 2023
Q2 2023 Reduced −161K −$14M −17.1% 782K Aug 11, 2023
Q1 2023 Added +37K +$2.9M +4.0% 943K May 12, 2023
Q4 2022 Reduced −224K −$17M −19.8% 907K Feb 13, 2023
Q3 2022 Added +135K +$13M +13.6% 1.1M Nov 10, 2022
Q2 2022 Reduced −140K −$14M −12.3% 995K Aug 11, 2022
Q1 2022 Added +328K +$37M +40.7% 1.1M May 13, 2022
Q4 2021 Added +117K +$14M +17.0% 807K Feb 14, 2022
Q3 2021 Reduced −8K −$870K −1.1% 690K Nov 12, 2021
Q2 2021 Added +307K +$29M +78.8% 697K Aug 13, 2021
Q1 2021 First covered 390K May 14, 2021
Data through Q1 2026 · filed May 15, 2026
21 grouped rows from 21 quarters

More Dalio positions

Common questions

Does Ray Dalio own EW?

Yes. As of Q1 2026, Ray Dalio disclosed 172K shares of EW, worth $14M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ray Dalio buy EW?

Ray Dalio held EW since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ray Dalio sell EW?

The quarter-by-quarter table above shows each sale and reduction Ray Dalio disclosed in EW. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of EW does Ray Dalio own?

Ray Dalio disclosed 172K shares of EW as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ray Dalio pay for EW?

Ray Dalio began building the EW position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.